Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-06-21

Clinical Trial Update: SER150 vs Placebo in Diabetic Kidney Disease [Phase 2, Phase 3]

View source ↗

Summary

SER150 vs placebo trial in diabetic kidney disease has completed its Phase 2/3 program.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SER150

Snippet

Sponsor: Serodus AS | Conditions: Diabetic Kidney Disease | Phase 2, Phase 3 | Status: COMPLETED